id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-2219-0001,FDA,FDA-2025-N-2219,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Pharmacogenetic Assessment System,Rule,Final Rule,2025-08-21T04:00:00Z,2025,8,,,2025-08-21T17:13:17Z,2025-16037,0,0,09000064b8f0b340